Given the patient's worsening symptoms, the decision was made to proceed with an aortic valve replacement as a long term solution.
[**6-24**] echocardiogram with ejection fraction of 20% to 25% with multiple wall motion abnormalities including apical akinesis, anteroseptal hypokinesis/akinesis, inferior hypokinesis/akinesis as well as lateral hypokinesis/akinesis.
Coumadin 5 mg po q day 2.
Lipitor 20 mg po q day 3.
Mavik 4 mg po q day 4.
Lasix 40 mg po q day 5.
Toprol XL 25 mg po q day  ALLERGIES:  No known drug allergies.
SUMMARY OF HOSPITAL COURSE:  The patient was admitted to cardiac surgery service.
Given symptomatic aortic insufficiency and also history of congestive heart failure, it was decided that a surgical intervention would be appropriate.
On [**2131-10-31**], the patient underwent aortic valve replacement with a 23 mm Carbomedics mechanical valve.
The procedure was without any complications.
The patient tolerated the procedure well.
The patient remained intubated and was transferred to the Intensive Care Unit for further management in stable condition.
The patient continued to have excellent oxygenation on minimal supplemental oxygen.
Anticoagulation with Coumadin was restarted.
His pacing wires were removed on postoperative day 3.
His urine catheter was removed on postoperative day 2.
The patient was also started on intravenous heparin on postoperative day 3 given slow rise in the NR level.
Severe aortic insufficiency, status post aortic valve replacement with a 23 mm Carbomedics mechanical valve.
Lasix 20 mg po bid x14 days 2.
Lipitor 20 mg po q day 3.
Lopressor 50 mg po bid 4.
Coumadin 7.5 mg on [**2131-11-6**] and 7.5 mg on [**2131-11-7**] (to follow up at the [**Hospital 197**] Clinic for further dosing).
Potassium chloride 20 milliequivalents po bid x14 days 6.
Colace 100 mg po bid 7.
Percocet 1 to 2 tablets po q 4 to 6 hours prn pain  DISCHARGE INSTRUCTIONS: 1.
The patient is to follow up at the [**Hospital 197**] Clinic in two days to have his INR levels drawn and his Coumadin levels adjusted.
